Wirth joins Epix Medical board

Peter Wirth, an executive vice president and chief legal officer for Genzyme, has been elected to the board of directors of Epix Medical, a Cambridge, MA-based MRI contrast agent developer. Wirth handles legal and corporate development for the Genzyme molecular oncology and Geltex pharmaceuticals business units.

By AuntMinnie.com staff writers
August 30, 2001

Related Reading

Epix net loss grows in Q2, July 27, 2001

Epix trims net loss, April 27, 2001

Epix, InSightec, Brigham and Women's team up, March 12, 2001

Epix loss widens in 2000, February 16, 2001

Epix CEO joins board of contrast agent association, February 9, 2001

Copyright © 2001 AuntMinnie.com

Page 1 of 606
Next Page